Author

Thomas Reiberger

SUPPRESSION OF THE PITUITARY-ADRENAL AXIS AND PROGNOSTIC VALUE OF SERUM CORTISOL IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
SUPPRESSION OF THE PITUITARY-ADRENAL AXIS AND PROGNOSTIC VALUE OF SERUM CORTISOL IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Thomas Reiberger  et al.

PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER
PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER

Thomas Reiberger  et al.

ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS
ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS

Thomas Reiberger  et al.

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

Thomas Reiberger  et al.

THE ALPHA-1 ANTITRYPSIN PI*Z ALLELE INDEPENDENTLY PREDICTS LIVER TRANSPLANTATION/DEATH IN ACLD PATIENTS
THE ALPHA-1 ANTITRYPSIN PI*Z ALLELE INDEPENDENTLY PREDICTS LIVER TRANSPLANTATION/DEATH IN ACLD PATIENTS

Thomas Reiberger  et al.

CARVEDILOL INDUCES HIGHER HVPG RESPONSE RATES AND IS ASSOCIATED WITH LOWER RATES OF VARICEAL REBLEEDING THAN PROPRANOLOL IN SECONDARY PROPHYLAXIS OF PORTAL HYPERTENSION - A RETROSPECTIVE COHORT STUDY
CARVEDILOL INDUCES HIGHER HVPG RESPONSE RATES AND IS ASSOCIATED WITH LOWER RATES OF VARICEAL REBLEEDING THAN PROPRANOLOL IN SECONDARY PROPHYLAXIS OF PORTAL HYPERTENSION - A RETROSPECTIVE COHORT STUDY

Thomas Reiberger  et al.

FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Thomas Reiberger  et al.

CLINICAL COURSE OF FURTHER DECOMPENSATION/MORTALITY IN PATIENTS WITH CIRRHOSIS AND ASCITES AS THE FIRST SINGLE DECOMPENSATION EVENT – AN INCEPTION COHORT STUDY
CLINICAL COURSE OF FURTHER DECOMPENSATION/MORTALITY IN PATIENTS WITH CIRRHOSIS AND ASCITES AS THE FIRST SINGLE DECOMPENSATION EVENT – AN INCEPTION COHORT STUDY

Thomas Reiberger  et al.

CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Thomas Reiberger  et al.

A FIB-4/VITRO SEQUENCE ALLOWS FOR DIAGNOSIS OF COMPENSATED ADVANCED CHRONIC LIVER DISEASE AND RISK STRATIFICATION FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
A FIB-4/VITRO SEQUENCE ALLOWS FOR DIAGNOSIS OF COMPENSATED ADVANCED CHRONIC LIVER DISEASE AND RISK STRATIFICATION FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION

Thomas Reiberger  et al.

RECENT AUSTRIAN EPIDEMIOLOGICAL DATA ON HEPATITIS D VIRUS
RECENT AUSTRIAN EPIDEMIOLOGICAL DATA ON HEPATITIS D VIRUS

Thomas Reiberger  et al.

PROGNOSTIC UTILITY OF THE BAVENO VII CRITERIA FOR A CLINICALLY SIGNIFICANT DECREASE IN LIVER STIFFNESS MEASUREMENT AFTER HCV-CURE
PROGNOSTIC UTILITY OF THE BAVENO VII CRITERIA FOR A CLINICALLY SIGNIFICANT DECREASE IN LIVER STIFFNESS MEASUREMENT AFTER HCV-CURE

Thomas Reiberger  et al.

THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE
THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE

Thomas Reiberger  et al.

VALIDATION AND REFINEMENT OF THE BAVENO VII CRITERIA FOR RISK STRATIFICATION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE AFTER HCV-CURE
VALIDATION AND REFINEMENT OF THE BAVENO VII CRITERIA FOR RISK STRATIFICATION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE AFTER HCV-CURE

Thomas Reiberger  et al.

NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION
NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION

Thomas Reiberger  et al.

ELIMINATE: A PCR RECORD-BASED HCV MACRO-ELIMINATION PROJECT IN AUSTRIA
ELIMINATE: A PCR RECORD-BASED HCV MACRO-ELIMINATION PROJECT IN AUSTRIA

Thomas Reiberger  et al.

Item 21 - 36 / 36
1
2